Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Increased secretion of gastrin (ICD-10 Code: E16.4)
Summary
Increased secretion of gastrin is a condition characterized by abnormally high levels of the hormone gastrin, which stimulates gastric acid production. This can lead to gastrointestinal symptoms and may be associated with underlying disorders affecting the stomach or pancreas. Clinical evaluation is often necessary to determine the cause and appropriate management.
Causes
Potential causes include gastrin-secreting tumors (e.g., gastrinomas), chronic atrophic gastritis, or conditions that disrupt normal gastric acid regulation. Some cases may arise from idiopathic factors or other endocrine disorders affecting hormone balance.
Risk Factors
Risk factors include a personal or family history of neuroendocrine tumors, chronic inflammatory conditions of the stomach, or genetic syndromes associated with hormone-secreting tumors. Age and gender may also influence susceptibility, though specific patterns vary.
Symptoms
Symptoms may include abdominal pain, heartburn, diarrhea, or signs of peptic ulcer disease. Excessive gastrin can lead to increased acid production, causing mucosal irritation or complications like bleeding or obstruction.
Diagnosis
Diagnosis typically involves measuring serum gastrin levels, assessing gastric acid output, and imaging studies (e.g., endoscopy or CT scans) to identify underlying causes. Additional tests may evaluate for associated conditions like Zollinger-Ellison syndrome.
Treatment Options
Treatment focuses on addressing the underlying cause, such as surgical removal of tumors or management of gastritis. Medications to reduce acid production (e.g., proton pump inhibitors) may alleviate symptoms. Dietary modifications and monitoring for complications are also common.
Prognosis and Follow-Up
Prognosis depends on the underlying cause and timeliness of treatment. Early intervention often improves outcomes, but chronic cases may require ongoing management. Regular follow-up with gastrin level monitoring and imaging is typically recommended.
Complications
Complications can include severe peptic ulcers, gastrointestinal bleeding, or malabsorption due to acid-induced mucosal damage. In rare cases, untreated gastrin excess may lead to tumor progression or metastasis.
Lifestyle & Prevention
Lifestyle modifications, such as avoiding trigger foods (e.g., spicy or acidic items) and managing stress, may help reduce symptoms. Preventive measures focus on early detection of underlying conditions through regular medical evaluations.
When to Seek Professional Help
Seek medical attention if experiencing persistent abdominal pain, unexplained weight loss, or signs of gastrointestinal bleeding (e.g., black stools or vomiting blood). Prompt evaluation is important for diagnosing and treating the underlying cause.
Tips for Medical Coders
Document the clinical context, including symptoms, diagnostic findings, and any associated conditions (e.g., gastrinoma or gastritis). Ensure documentation supports the diagnosis of increased gastrin secretion and aligns with the ICD-10-CM guidelines for code E16.4.
Medical Policies and Guidelines
Related policies from health plans
E16.4 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.